Genervon Continues to Focus on Nerve Cell Development Factor as ALS Treatment
News
Genervon Biopharmaceuticals says its efforts to develop treatments for ALS and other neurodegenerative diseases continue to focus on a factor that regulates stem cells’ evolution into nerve cells. It continues ... Read more